Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Bresson

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Advances in Medical Oncology|April 7, 2023
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncologyVladimir Lazar, Baolin Zhang, Shai Magidi, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumorsVladimir Lazar, Eric Raymond, Shai Magidi, et al.
Cancer Medicine|March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancerBenjamin Solomon, Ana Callejo, Jair Bar, et al.
Nature Medicine|April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trialJordi Rodon, Jean-Charles Soria, Raanan Berger, et al.
NPJ Precision Oncology|April 29, 2021
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survivalVladimir Lazar, Shai Magidi, Nicolas Girard, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high <i>ACE2</i>-expressing normal lungVladimir Lazar, Jacques Raynaud, Shai Magidi, et al.
JCO Precision Oncology|September 15, 2022
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant TherapiesVladimir Lazar, Nicolas Girard, Eric Raymond, et al.
Oncotarget|May 7, 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancerVladimir Lazar, Eitan Rubin, Stephane Depil, et al.
Oncotarget|March 12, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patientsWafik S El-Deiry, Catherine Bresson, Fanny Wunder, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Advances in Medical Oncology|April 7, 2023
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncologyVladimir Lazar, Baolin Zhang, Shai Magidi, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumorsVladimir Lazar, Eric Raymond, Shai Magidi, et al.
Cancer Medicine|March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancerBenjamin Solomon, Ana Callejo, Jair Bar, et al.
Nature Medicine|April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trialJordi Rodon, Jean-Charles Soria, Raanan Berger, et al.
NPJ Precision Oncology|April 29, 2021
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survivalVladimir Lazar, Shai Magidi, Nicolas Girard, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high <i>ACE2</i>-expressing normal lungVladimir Lazar, Jacques Raynaud, Shai Magidi, et al.
JCO Precision Oncology|September 15, 2022
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant TherapiesVladimir Lazar, Nicolas Girard, Eric Raymond, et al.
Oncotarget|May 7, 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancerVladimir Lazar, Eitan Rubin, Stephane Depil, et al.
Oncotarget|March 12, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patientsWafik S El-Deiry, Catherine Bresson, Fanny Wunder, et al.
Pageof 2